|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q3 FY2016
As of Sep 30, 2016
|
Q3 FY2015
As of Sep 30, 2015
|
Q3 FY2014
As of Sep 30, 2014
|
Q3 FY2013
As of Sep 30, 2013
|
Q3 FY2012
As of Sep 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Cash | |||||||||||||
| Restricted cash | |||||||||||||
| Accounts receivable, net of allowance for expected credit losses | |||||||||||||
| Other receivables and prepayment | |||||||||||||
| Current portion of long-term receivables | |||||||||||||
| Other receivables and prepayment, net | |||||||||||||
| Amounts due from associate | |||||||||||||
| Notes receivable | |||||||||||||
| Total current assets | |||||||||||||
| Non-current assets: | |||||||||||||
| Property and equipment, net | |||||||||||||
| Intangible assets, net | |||||||||||||
| Goodwill | |||||||||||||
| Investment | |||||||||||||
| Right-of-use assets | |||||||||||||
| Deferred tax assets | |||||||||||||
| Other assets | |||||||||||||
| Other receivables, net (long term) | |||||||||||||
| Total non-current assets | |||||||||||||
| TOTAL ASSETS | |||||||||||||
| Liabilities | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Tax payable | |||||||||||||
| Accrued liabilities and other payables | |||||||||||||
| Amounts due to associate | |||||||||||||
| Contract liabilities | |||||||||||||
| Lease liabilities – current portion | |||||||||||||
| Amounts due to related parties | |||||||||||||
| Total current liabilities | |||||||||||||
| Non-current liabilities: | |||||||||||||
| Lease liabilities – non-current portion | |||||||||||||
| Accrued liabilities and other payables | |||||||||||||
| Deferred tax liabilities | |||||||||||||
| Total non- current liabilities | |||||||||||||
| TOTAL LIABILITIES | |||||||||||||
| Mezzanine equity | |||||||||||||
| Redeemable preferred shares, $ 0.01 par value, 21,794,872 shares authorized, issued and outstanding at December 31, 2022 and 2021 | |||||||||||||
| Redeemable preferred shares, $2.4 par value, 90,812 shares authorized, issued and outstanding at December 31, 2023 and 2022 | |||||||||||||
| Shareholders’ Equity | |||||||||||||
| Preferred shares, $2.4; 10,417 shares authorized, issued and outstanding at December 31, 2023 and 2022 | |||||||||||||
| Ordinary shares, $2.4 par value; 125,000,000 shares authorized; 2,439,727 and 2,052,078 shares issued and outstanding at December 31, 2023 and 2022 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total accumulated deficit | |||||||||||||
| Accumulated other comprehensive income/(loss) | |||||||||||||
| (deficit)/equity attributable to owners of the company | |||||||||||||
| Total (deficit)/equity attributable to owners of the company | |||||||||||||
| Non-controlling interest | |||||||||||||
| Total Shareholders’ (Deficit)/Equity | |||||||||||||
| TOTAL LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY | |||||||||||||
Loading...